CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Multiple Myeloma
City of Hope Medical Center
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Janssen Research & Development, LLC
Gilead Sciences
M.D. Anderson Cancer Center
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Masonic Cancer Center, University of Minnesota
University of California, San Francisco
Massachusetts General Hospital
Essen Biotech
Mayo Clinic
Thomas Jefferson University
Northside Hospital, Inc.
University of Rochester
Caribou Biosciences, Inc.
Indapta Therapeutics, INC.
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
University of Liege